Akorn, Inc. (NASDAQ:AKRX)

CAPS Rating: 5 out of 5 81.91

The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.

Caps

How do you think AKRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

200 Outperform
17 Underperform
 

All-Star Players

32 Outperform
3 Underperform
 

Wall Street

8 Outperform
0 Underperform
 

Top AKRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

HealthcareGuy (96.83)
Submitted December 29, 2010

Akorn, is a generic pharma company that has been remade by successful healthcare turnaround investor John Kapoor (Chariman of the Board). The major catalyst for this name, will be FDA approval of AKRX’s generic version of Vancocin (first to file,… More

OriginalBarnacle (93.13)
Submitted August 23, 2007

P/b = 10.2P/S = 12.7No earningsMargins are worse with increasing inventory.Price change over 106%

AKRX VS S&P 500 (SPY)

Fools bullish on AKRX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about AKRX.

Recs

0
Member Avatar OklaBoston (50.32) Submitted: 1/25/2019 12:59:19 PM : Outperform Start Price: $4.29 AKRX Score: -0.79

Having traded above $30.00 in the past among other things.

Recs

0
Member Avatar TerryHoodSr (68.76) Submitted: 5/6/2016 2:22:51 PM : Outperform Start Price: $20.10 AKRX Score: -113.30

Potential buying opportunity

Recs

0
Member Avatar murphydevani (< 20) Submitted: 8/26/2015 1:13:58 AM : Underperform Start Price: $39.62 AKRX Score: +133.20

Target $37 - $36

Leaderboard

Find the members with the highest scoring picks in AKRX.

Score Leader

branwann

branwann (< 20) Score: +710.11

The Score Leader is the player with the highest score across all their picks in AKRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
seanchile 70.15 1/18/2008 8/23/2010 Underperform 3Y $7.87 -43.58% +114.53% +158.11 0 Comment
dragondragon18 97.07 1/15/2008 Underperform 1Y $7.59 -41.50% +108.44% +149.94 0 Comment
studpicker 30.27 2/15/2008 Underperform NS $6.73 -34.03% +115.56% +149.59 0 Comment
ToePic < 20 2/25/2008 Underperform NS $6.56 -32.32% +113.28% +145.59 0 Comment
postlapsaria 63.62 1/4/2011 Underperform 5Y $5.64 -21.28% +118.76% +140.04 0 Comment
Jkon88 < 20 11/15/2007 Underperform NS $7.02 -36.75% +98.58% +135.34 0 Comment
shoutao 94.94 11/19/2007 Underperform NS $6.80 -34.71% +100.02% +134.73 0 Comment
dafonz223 64.02 11/15/2007 Underperform 3M $6.95 -36.12% +98.45% +134.56 0 Comment
fiduke 59.20 9/16/2010 Underperform 5Y $3.96 +12.12% +145.50% +133.38 0 Comment
murphydevani < 20 8/26/2015 Underperform 1Y $39.62 -88.79% +44.40% +133.20 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackUltraLong < 20 5/3/2018 Outperform NS $11.40 -61.05% +6.15% -67.20 1 Comment
TrackJimCramer 85.40 3/24/2015 Outperform 3W $48.16 -90.78% +32.83% -123.61 0 Comment
TrackWallachBeth 43.81 10/14/2014 Outperform NS $34.11 -86.98% +47.21% -134.19 0 Comment
TrackRBCCapMkts 87.19 9/29/2014 Outperform NS $36.08 -87.69% +41.37% -129.06 0 Comment
TrackMerrill 96.02 9/27/2012 Outperform NS $13.10 -66.11% +92.77% -158.87 0 Comment
TrackTMFFoolish8 < 20 3/8/2012 Outperform 5Y $11.69 +16.94% +3.33% +13.60 8/31/2012 @ $13.67 0 Comment
TrackNeedham 90.45 1/18/2012 Outperform NS $10.88 -59.19% +114.50% -173.69 0 Comment
TrackDeutscheSec 85.90 9/16/2011 Outperform NS $9.03 +49.61% +11.08% +38.54 7/23/2012 @ $13.51 0 Comment
TrackRodmanRen < 20 7/15/2010 Outperform NS $3.19 +39.18% +153.05% -113.87 0 Comment
TrackCreditSuiss 88.94 2/26/2009 Outperform NS $1.97 +125.38% +262.80% -137.42 0 Comment
TrackFBRCapitalM 87.38 10/13/2006 Outperform NS $4.09 +61.86% -2.25% +64.11 2/8/2008 @ $6.62 0 Comment

Advertisement